ARCHIVES

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

This article is from The Cancer Letter archive.

Vol. 30 No. 39 | October 15, 2004

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Cooperative Group Contract Extension, Nutrition Research Training Grants

February 6, 1981

IOM Calls For Rapid Reform Of Health Case System.

March 9, 2001

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

Clinical Research PA In Lung Cancer Is Released

August 16, 1991

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Shared Specimen Resource Needed, GYN Review Finds.

February 1, 2002